Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A case of metastatic eccrine porocarcinoma without actionable mutations treated with carboplatin and epirubicin chemotherapy.

The Australasian journal of dermatology - 1 Aug 2021

Tahara Jumpei, Ishida Yoshihiro, Otsuka Atsushi, Komatsu-Fujii Takayoshi, Yamamura Kentaro, Kaku Yo, Endo Yuichiro, Nomura Takashi, Irie Hiroyuki, Kabashima Kenji

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epirubicin

Share to Mutation

Share to Treatment Outcome

Source

Identifiers

PMID: 33729560
DOI: 10.1111/ajd.13584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A case of metastatic eccrine porocarcinoma without actionable mutations treated with carboplatin and epirubicin chemotherapy.PMID 33729560Read ↗

Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 casesSemantic proximity Read ↗

HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.Semantic proximity Read ↗

High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.Semantic proximity Read ↗

Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.Semantic proximity Read ↗

Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreasSemantic proximity Read ↗

Malignant fibroadenoma with CHEK2 mutation: a novel case.Semantic proximity Read ↗

A noncancerous variant of xeroderma pigmentosum type D associated with novel heterozygous missense ERCC2 gene mutation.Semantic proximity Read ↗

Intrahepatic Cholangiocarcinoma With Extrahepatic Metastasis and High Tumor Mutation Burden: Case of Complete Pathological Response to Cisplatin/Gemcitabine/Pembrolizumab.Semantic proximity Read ↗

Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.Semantic proximity Read ↗

Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.Semantic proximity Read ↗

A sporadic patient with acrokeratosis verruciformis of Hopf and a novel ATP2A2 mutation.Semantic proximity Read ↗

Phacomatosis pigmentokeratotica: a follow-up report with fatal outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.